Neuroprotective effect of the recombinant human leukemia inhibitory factor in mice with an experimental cuprizone model of multiple sclerosis: possible mechanisms
Aim. To investigate the effects of the rhLIF recombinant human leukemia inhibitory factor on the structural and functional changes in the central nervous system in the cuprizone-induced experimental model of multiple sclerosis in mice and to evaluate the involvement of the brain macrophages, T-lymph...
Saved in:
| Published in: | Вiopolymers and Cell |
|---|---|
| Date: | 2018 |
| Main Authors: | Labunets, I.F., Rodnichenko, A.E., Melnyk, N.O, Rymar, S.E, Utko, N.A., Gavrulyk-Skyba, G.O., Butenko, G.M. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут молекулярної біології і генетики НАН України
2018
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/154362 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Neuroprotective effect of the recombinant human leukemia inhibitory factor in mice with an experimental cuprizone model of multiple sclerosis: possible mechanisms / I.F. Labunets, A.E.. Rodnichenko, N.O Melnyk, S.E. Rymar, N.A. Utko, G.O. Gavrulyk-Skyba, G.M. Butenko // Вiopolymers and Cell. — 2018. — Т. 34, № 5. — С. 350-360. — Бібліогр.: 36 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Association of the leukemia inhibitory factor gene polymorphism rs929271 with idiopathic mild intellectual disability
by: Gulkovskyi, R.V., et al.
Published: (2015)
by: Gulkovskyi, R.V., et al.
Published: (2015)
Association of the leukemia inhibitory factor gene polymorphism rs929271 with idiopathic mild intellectual disability
by: R. V. Gulkovskyi, et al.
Published: (2015)
by: R. V. Gulkovskyi, et al.
Published: (2015)
Pharmacological effect of aminoferrocene in mice with L1210 leukemia
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
Pharmacological effect of aminoferrocene in mice with L1210 leukemia
by: V. F. Chekhun, et al.
Published: (2015)
by: V. F. Chekhun, et al.
Published: (2015)
Pain Sensitivity and Behavioral Indices in Mice Exposed to Glutamate Toxicity: Neuroprotective Effects of Vitamin Supplementation
by: T. S. Adu, et al.
Published: (2017)
by: T. S. Adu, et al.
Published: (2017)
Multiple sclerosis
by: Palinskyy, I.Z.
Published: (2008)
by: Palinskyy, I.Z.
Published: (2008)
Aspects of the creation of neuroprotective antiinflammatory drugs
by: I. S. Chekman, et al.
Published: (2019)
by: I. S. Chekman, et al.
Published: (2019)
Systemic disorders in patients with multiple sclerosis
by: I. A. Grigorova
Published: (2018)
by: I. A. Grigorova
Published: (2018)
Hypochlorous model of systemic sclerosis induction
by: L. M. Zaiats, et al.
Published: (2020)
by: L. M. Zaiats, et al.
Published: (2020)
Antioxidant Activity-Mediated Neuroprotective Effects of an Antagonist of AT1 Receptors, Candesartan, Against Cerebral Ischemia and Edema in Rats
by: Panahpour, H., et al.
Published: (2013)
by: Panahpour, H., et al.
Published: (2013)
Current approaches to pathogenetic therapy of multiple sclerosis
by: Ye. Chernenko, et al.
Published: (2015)
by: Ye. Chernenko, et al.
Published: (2015)
The inhibitory potential of calixarenes against nucleotide pyrophosphatase/phosphodiesterase 1
by: V. M. Buldenko, et al.
Published: (2017)
by: V. M. Buldenko, et al.
Published: (2017)
Pain and vertebrogenic syndromes in patients with multiple sclerosis (Review of Literature)
by: T. Nehrych, et al.
Published: (2018)
by: T. Nehrych, et al.
Published: (2018)
Inhibitory effect of benzimidazole derivatives on cholinesterases of animals in the presence of different substrates
by: N. E. Basova, et al.
Published: (2014)
by: N. E. Basova, et al.
Published: (2014)
Mesenchymal Stem Cells Conditioned Medium as a Source of Neuroprotective Factors
by: E. Shekiova, et al.
Published: (2018)
by: E. Shekiova, et al.
Published: (2018)
ATYPICAL BRAF MUTATIONS IN HAIRY CELL LEUKEMIA: DIAGNOSTIC AND THERAPEUTIC CONSIDERATIONS
by: LANGABEER, S.E., et al.
Published: (2025)
by: LANGABEER, S.E., et al.
Published: (2025)
Changes of antinociceptive potential combinations of analgesics with methylprednisolone in experimental multiple sclerosis
by: O. O. Nefodov, et al.
Published: (2015)
by: O. O. Nefodov, et al.
Published: (2015)
Frequency and spectrum of atypical BCR-ABL1 transcripts in chronic myeloid leukemia
by: Kearney, L., et al.
Published: (2023)
by: Kearney, L., et al.
Published: (2023)
Inhibitory potential of polyhydroxylated fullerenes against protein tyrosine phosphatase 1B
by: O. L. Kobzar, et al.
Published: (2015)
by: O. L. Kobzar, et al.
Published: (2015)
Albumin as a parameter permeability of the blood-brain barrier in multiple sclerosis patients
by: M. E. Chernenko
Published: (2013)
by: M. E. Chernenko
Published: (2013)
Dephosphorylation of tuberous sclerosis complex 2 by serine/threonine protein phosphatase 5
by: Malanchuk, O.M., et al.
Published: (2008)
by: Malanchuk, O.M., et al.
Published: (2008)
Expression and secretion of human recombinant LIF by genetically modified mammalian cells
by: Rymar, S.Yu., et al.
Published: (2011)
by: Rymar, S.Yu., et al.
Published: (2011)
Neuroprotective Effects of Macrovipera Lebetina Snake Venom in the Model of Alzheimer's Disease
by: N. A. Ghazaryan, et al.
Published: (2017)
by: N. A. Ghazaryan, et al.
Published: (2017)
Enzyme blood level disorder as a marker of metabolic processes severity in multiple sclerosis
by: E. V. Markovskaja
Published: (2014)
by: E. V. Markovskaja
Published: (2014)
Clinical activity risk factors and long-term prognosis of relapsing-remitting multiple sclerosis
by: T. A. Kobys, et al.
Published: (2014)
by: T. A. Kobys, et al.
Published: (2014)
Freezing influences, the exposure of IgG glycans in sera from multiple sclerosis patients
by: M. Bozhenko, et al.
Published: (2020)
by: M. Bozhenko, et al.
Published: (2020)
Interrelation of cognitive functions disturbance and uric acid metabolism in railroads workers with disseminated sclerosis
by: Ju. Naumenko, et al.
Published: (2015)
by: Ju. Naumenko, et al.
Published: (2015)
Enzyme blood level disorder as a marker of metabolic processes severity in multiple sclerosis
by: Markovskaya, E.V
Published: (2014)
by: Markovskaya, E.V
Published: (2014)
Study of the sites of plasminogen molecule which are responsible for inhibitory effect of Lys-plasminogen on platelet aggregation
by: Y. M. Roka-Moya, et al.
Published: (2014)
by: Y. M. Roka-Moya, et al.
Published: (2014)
Inhibitory action of fungicides on germination of fungal spores of Cercospora beticola Sacc. and Alternaria alternata Keissl.
by: O. S. Vlasiuk
Published: (2014)
by: O. S. Vlasiuk
Published: (2014)
Neuroprotective Effect of Vitamin E in a Kainate-Induced Rat Model of Temporal Lobe Epilepsy
by: Kiasalari, Z., et al.
Published: (2014)
by: Kiasalari, Z., et al.
Published: (2014)
Peculiarities of the neuroprotective impact of peptide preparations on memory and the ability to learn in rats in condition of alcohol encephalopathy
by: O. P. Sokolyk
Published: (2019)
by: O. P. Sokolyk
Published: (2019)
Neuroprotective Effect of Placental Factors in Model of Glutamate Induced Toxicity in Newborn Rat Brain Cells
by: O. V. Chub, et al.
Published: (2016)
by: O. V. Chub, et al.
Published: (2016)
Neuroprotective Effect of Vitamin E in a Kainate-Induced Rat Model of Temporal Lobe Epilepsy
by: Z. Kiasalari, et al.
Published: (2014)
by: Z. Kiasalari, et al.
Published: (2014)
Neuroprotective and Antiapoptotic Potential of Trigonelline in a Striatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease
by: Mirzaie, M., et al.
Published: (2016)
by: Mirzaie, M., et al.
Published: (2016)
Diagnosis of chronic myelomonocytic leukemia
by: L. M. Skljarenko, et al.
Published: (2018)
by: L. M. Skljarenko, et al.
Published: (2018)
Clinical course peculiarities in patients with multiple sclerosis in vinnytsia region on the basis of vitamin D content
by: S. L. Malyk
Published: (2015)
by: S. L. Malyk
Published: (2015)
Influence of the dose of human umbilical cord mesenchymal stem cells on acute inflammation on the peritonitis model in mice
by: P. A. Pikus, et al.
Published: (2019)
by: P. A. Pikus, et al.
Published: (2019)
Mathematical modeling of red blood cell shape change in early neuroprotection with moderate therapeutic effect of hypothermia
by: O. M. Morozova, et al.
Published: (2020)
by: O. M. Morozova, et al.
Published: (2020)
Stimulation of CB1 Cannabinoid and NMDA Receptors Increases Neuroprotective Effect Against Diazinon-Induced Neurotoxicity
by: F. Bahrami, et al.
Published: (2013)
by: F. Bahrami, et al.
Published: (2013)
Similar Items
-
Association of the leukemia inhibitory factor gene polymorphism rs929271 with idiopathic mild intellectual disability
by: Gulkovskyi, R.V., et al.
Published: (2015) -
Association of the leukemia inhibitory factor gene polymorphism rs929271 with idiopathic mild intellectual disability
by: R. V. Gulkovskyi, et al.
Published: (2015) -
Pharmacological effect of aminoferrocene in mice with L1210 leukemia
by: Chekhun, V.F., et al.
Published: (2015) -
Pharmacological effect of aminoferrocene in mice with L1210 leukemia
by: V. F. Chekhun, et al.
Published: (2015) -
Pain Sensitivity and Behavioral Indices in Mice Exposed to Glutamate Toxicity: Neuroprotective Effects of Vitamin Supplementation
by: T. S. Adu, et al.
Published: (2017)